Apostolos Dalagiorgos (MBA)

Apostolos Dalagiorgos has a diverse work experience in the pharmaceutical industry. Apostolos worked as a Product Manager & Area Sales Manager at Elpen Pharmaceutical Co. Inc. from 2020 onwards. In this role, they managed both Neurological & Psychiatric products and was responsible for launching new drugs for Alzheimer's disease and Schizophrenia/Bipolar Disorder. Apostolos also developed marketing plans for various products and implemented tactical plans through excellence in execution and adoption of new technology.

Prior to that, Apostolos worked as a Product Manager Pharmaceuticals at Alcon, a Novartis company, from 2013 to 2016. In this role, they managed the Ophthalmic Pharma portfolio, including prescription drugs for Glaucoma and Inflammations, as well as over-the-counter artificial tears. Apostolos was responsible for the strategy and planning for the portfolio.

Before joining Alcon, Apostolos worked at UCB Pharma from 2009 to 2013 in various roles. Apostolos started as a Product Specialist for CNS products from 2009 to 2010, then worked as a Junior Product Manager from 2010 to 2011, and finally served as a Brand Manager from 2012 to 2013.

Overall, Apostolos Dalagiorgos has extensive experience in product management, marketing, and strategic planning in the pharmaceutical industry, with a focus on CNS and ophthalmic pharmaceuticals.

Apostolos Dalagiorgos completed a Master of Business Administration (M.B.A.) in Health Economics from the Ethnikon kai Kapodistriakon Panepistimion Athinon from 2015 to 2017. Prior to this, they obtained a Bachelor of Science (BS) in Chemistry from the Aristotle University of Thessaloniki (AUTH), although the specific dates of their undergraduate education were not provided.